# Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset

> **NCT01842542** · NA · TERMINATED · sponsor: **Neuronetics** · enrollment: 25 (actual)

## Conditions studied

- Depression, Postpartum

## Interventions

- **DEVICE:** NeuroStar Transcranial Magnetic Stimulation (TMS)

## Key facts

- **NCT ID:** NCT01842542
- **Lead sponsor:** Neuronetics
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2015-07
- **Final completion:** 2015-08
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01842542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01842542, "Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01842542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*